This Biopharma Company Is Tackling Diseases That Badly Need Solutions

Sign up for this week’s All Access giveaway here

Laxminarayan Bhat, Founder, President and CEO of Reviva Pharmaceuticals Holdings Inc RVPH was a guest on Benzinga’s All Access on October 21, 2022.

Headquartered in Cupertino, California, Reviva is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs and burden to society, patients, and their families. 

Watch the full interview here:

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.


 

RVPH Logo
RVPHReviva Pharmaceuticals Holdings Inc
$0.8551-1.36%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
10.01
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:
Comments
Loading...